These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19552609)

  • 21. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
    Ceresoli GL; Zucali PA; Favaretto AG; Grossi F; Bidoli P; Del Conte G; Ceribelli A; Bearz A; Morenghi E; Cavina R; Marangolo M; Parra HJ; Santoro A
    J Clin Oncol; 2006 Mar; 24(9):1443-8. PubMed ID: 16549838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W; Kirschbaum A; Passlick B
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
    Pasello G; Marulli G; Polo V; Breda C; Bonanno L; Loreggian L; Rea F; Favaretto A
    Anticancer Res; 2012 Dec; 32(12):5393-9. PubMed ID: 23225442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
    Nakagawa K; Yamazaki K; Kunitoh H; Hida T; Gemba K; Shinkai T; Ichinose Y; Adachi S; Nambu Y; Saijo N; Fukuoka M
    Jpn J Clin Oncol; 2008 May; 38(5):339-46. PubMed ID: 18434338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic options in malignant pleural mesothelioma].
    Serke M; Loddenkemper R
    Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed therapy for malignant pleural mesothelioma.
    Puto K; Garey JS
    Ann Pharmacother; 2005 Apr; 39(4):678-83. PubMed ID: 15755794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ
    J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant pleural mesothelioma: current concepts in treatment.
    Tsiouris A; Walesby RK
    Nat Clin Pract Oncol; 2007 Jun; 4(6):344-52. PubMed ID: 17534390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in chemotherapy for malignant pleural mesothelioma.
    Sørensen JB
    Clin Respir J; 2008 Apr; 2(2):74-9. PubMed ID: 20298310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant mesothelioma of the pleura: place of surgery].
    Giudicelli R; Regnard JF; Astoul P; Ruffie P
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK; Ye Z; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Monberg MJ; Jänne PA;
    Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.
    Ris HB
    Lung Cancer; 2005 Jul; 49 Suppl 1():S65-8. PubMed ID: 15916831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current options for systemic therapy in mesothelioma.
    Jackman DM
    Semin Thorac Cardiovasc Surg; 2009; 21(2):154-8. PubMed ID: 19822287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview on ongoing or planned clinical trials in Europe.
    Favaretto A
    Lung Cancer; 2005 Jul; 49 Suppl 1():S117-21. PubMed ID: 15950791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
    Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
    Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant pleural mesothelioma: medical treatment update.
    Vorobiof DA; Mafafo K
    Clin Lung Cancer; 2009 Mar; 10(2):112-7. PubMed ID: 19362954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.